Early studies on miRNAs and CRC quickly focused on elucidating their relationship to effectors of known carcinogenic pathways, such as mRNAs involved in the Wnt/ß-catenin, PI3K/AKT, p53/c-MYC, and MAPK/ERK pathways. This evidence concerns the gene TP53 and colorectal carcinoma.